We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Randomized Controlled Cluster Trial of Resident Pay for Performance and Cardiovascular Outcomes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01590290
Recruitment Status : Unknown
Verified April 2012 by Robert Schutt, MD, University of Virginia.
Recruitment status was:  Recruiting
First Posted : May 2, 2012
Last Update Posted : May 2, 2012
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:

The purpose of this study is to determine if a pay for performance model in contrast to the traditional "fee for service" model may improve the number of patients discharged being treated in accordance with Joint Commission on Health Care JCAHO (a non-for profit organization that accredits health care organizations) standards and standard of care for management of hyperlipidemia

In this study the investigators will evaluate these two models by training resident physicians (doctors in training) on JCAHO core measures and specific criteria related to accepted standard of care for acute myocardial infarction and heart failure. The physicians will be randomized to a pay for performance or a fee for service model. Then a medical record review will be performed on patient records that received a discharge diagnosis of myocardial infarction or heart failure and were cared for by the physician subjects


Condition or disease Intervention/treatment Phase
Myocardial Infarction Heart Failure Other: financial compensation Phase 3

Study Design

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 38 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Randomized Controlled Cluster Trial of Resident Pay for Performance and Cardiovascular Outcomes
Study Start Date : April 2012
Estimated Primary Completion Date : April 2013

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arms and Interventions

Arm Intervention/treatment
Active Comparator: pay for performance Other: financial compensation
financial monetary reimbursement
No Intervention: no pay for performance


Outcome Measures

Primary Outcome Measures :
  1. compliance with composite pay for performance measure [ Time Frame: 1 month ]
    In patients discharged from the Coronary Care Unit, Acute Coronary Care Service, or General Medical Service with the discharge diagnosis of either heart failure or myocardial infarction, there is no difference in the rate of compliance with the composite score (see below; Heart Failure Score or Myocardial Infarction Score) between physicians reimbursed in a pay for performance scheme and those who receive no additional reimbursement.


Secondary Outcome Measures :
  1. heart failure composite score [ Time Frame: 1 month ]
    In patients discharged from the Coronary Care Unit, Acute Coronary Care Service, or General Medical Service with the discharge diagnosis of heart failure there is no difference between rate of compliance with Heart Failure Score between physicians reimbursed in a pay for performance scheme and those who receive no additional reimbursement.

  2. myocardial infarction score [ Time Frame: 1 month ]
    In patients discharged from the Coronary Care Unit, Acute Coronary Care Service, or General Medical Service with the discharge diagnosis of myocardial infarction there is no difference between the rate of compliance with Myocardial Infarction Score between physicians reimbursed in a pay for performance scheme and those who receive no additional reimbursement.

  3. readmission rate [ Time Frame: 30 days ]
    In patients discharged from the Coronary Care Unit, Acute Coronary Care Service, or General Medical Service with the discharge diagnosis heart failure there is no difference between 30-day readmission rate between patients that had an appointment less than 7 days and those that did not.


Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Physician inclusion: Resident physician on the Acute Cardiology Service, the Coronary Care Unit, or the General Medicine Service at the University of Virginia
  • Patient inclusion: discharge diagnosis of heart failure or myocardial infarction.

Exclusion Criteria:

  • Residents that are part of the study team
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01590290


Locations
United States, Virginia
University of Virginia Recruiting
Charlottesville, Virginia, United States, 22902
Contact: Robert C Schutt, MD    434-924-0000 ext 4234    rob.schutt@virginia.edu   
Principal Investigator: Robert C Schutt, MD         
Sponsors and Collaborators
University of Virginia
More Information

Responsible Party: Robert Schutt, MD, Resident, University of Virginia
ClinicalTrials.gov Identifier: NCT01590290     History of Changes
Other Study ID Numbers: 16033
First Posted: May 2, 2012    Key Record Dates
Last Update Posted: May 2, 2012
Last Verified: April 2012

Additional relevant MeSH terms:
Heart Failure
Infarction
Myocardial Infarction
Heart Diseases
Cardiovascular Diseases
Ischemia
Pathologic Processes
Necrosis
Myocardial Ischemia
Vascular Diseases